| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | mkt | Crystal structure of V30M mutated transthyretin in complex with gamma-mangostin | 4y9e | 60.38 |
| 2 | mkt | Crystal structure of V30M mutated transthyretin with bromide in complex with gamma-mangostin | 4y9f | 60.1 |
| 3 | 1fl | Structure of Wild Type Human Transthyretin in Complex with Diflunisal | 6e70 | 58.71 |
| 4 | tcw | V122I Transthyretin structure in complex with Tolcalpone | 5a6i | 57.65 |
| 5 | l57 | Human transthyretin (TTR) complexed with (Z)-((3,4-Dichloro-phenyl)-methyleneaminooxy)-acetic acid | 5e4o | 57.56 |
| 6 | jtk | Crystal structure of transthyretin in complex with CHF4795, a flurbiprofen analogue | 6r68 | 57.11 |
| 7 | 16v | The Structure of V122I Mutant Transthyretin in Complex with AG10 | 4hiq | 56.63 |
| 8 | jte | Crystal structure of transthyretin in complex with CHF5075, a flurbiprofen analogue | 6r67 | 56.21 |
| 9 | mks | Crystal structure of V30M mutated transthyretin in complex with alpha-mangostin | 4y9b | 54.8 |
| 10 | gen | V30M mutant human transthyretin (TTR) complexed with genistein (V30M:GEN) pH 7.5 | 3kgt | 54.74 |
| 11 | mks | Crystal structure of V30M mutated transthyretin with bromide in complex with alpha-mangostin | 4y9c | 54.55 |
| 12 | dz2 | Human transthyretin (TTR) complexed with N-(3,5-Dibromo-4-hydroxyphenyl)-2,5-dichlorobenzamide | 3eso | 54.39 |
| 13 | 57d | Crystal Structure of the Wild Type TTR Binding Chrysin (TTRwt:CHR) | 4des | 53.97 |
| 14 | diu | Crystal structure of transthyretin in complex with 3,5-diiodosalicylic acid | 3b56 | 53.7 |
| 15 | ft2 | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-3 | 4abv | 53.5 |
| 16 | gen | Wild type human transthyretin (TTR) complexed with genistein (TTRwt:GEN) pH 7.5 | 3kgu | 53.48 |
| 17 | 3m4 | Human transthyretin (TTR) complexed with 5-(2-ethoxyphenyl)-3-(pyridin-4-yl)-1,2,4-oxadiazole | 3p3u | 53.44 |
| 18 | dz3 | Human transthyretin (TTR) complexed with N-(3,5-Dibromo-4-hydroxyphenyl)-3,5-dimethyl-4-hydroxybenzamide | 3esp | 53.03 |
| 19 | qap | Crystal structure of V30M mutant human transthyretin complexed with caffeic acid phenethyl ester | 4qrf | 53.03 |
| 20 | lu2 | CRYSTAL STRUCTURE of HUMAN TRANSTHYRETIN IN COMPLEX WITH LUTEOLIN AT 1.1 A RESOLUTION | 4qxv | 52.87 |
| 21 | flf | Crystal structure of human transthyretin variant A25T in complex with flufenamic acid. | 3ozl | 52.65 |
| 22 | ifa | Crystal structure of transthyretin in complex with iododiflunisal-betaAlaOMe | 3fc8 | 52.38 |
| 23 | dif | Crystal structure of human wild-type transthyretin in complex with diclofenac | 3cfq | 52.24 |
| 24 | mil | STRUCTURAL ASPECTS OF INOTROPIC BIPYRIDINE BINDING: CRYSTAL STRUCTURE DETERMINATION TO 1.9 ANGSTROMS OF THE HUMAN SERUM TRANSTHYRETIN-MILRINONE COMPLEX | 1tlm | 52.13 |
| 25 | xlo | Wild-type Transthyretin in complex with 3-[(1E)-2-(2-Chloro-4-hydroxyphenyl)ethenyl]benzoic Acid | 5u4d | 51.91 |
| 26 | 3m3 | Human transthyretin (TTR) complexed with 4-(3-(2-flourophenoxy)propyl)-3,5-dimethyl-1H-pyrazole | 3p3t | 51.76 |
| 27 | ifb | Crystal structure of transthyretin in complex with iododiflunisal-betaAlaOH | 3fcb | 51.58 |
| 28 | 1fl | Human transthyretin (ttr) complexed with diflunisal | 3d2t | 51.54 |
| 29 | mku | Crystal structure of V30M mutated transthyretin in complex with 3-isomangostin | 4y9g | 50.88 |
| 30 | dz1 | Human transthyretin (TTR) complexed with N-(3,5-Dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide | 3esn | 50.82 |
| 31 | t33 | MECHANISM OF MOLECULAR RECOGNITION. STRUCTURAL ASPECTS OF 3,3'-DIIODO-L-THYRONINE BINDING TO HUMAN SERUM TRANSTHYRETIN | 1tha | 50.79 |
| 32 | 30z | Crystal structure of V30M mutant human transthyretin complexed with nordihydroguaiaretic acid | 4pwj | 50.68 |
| 33 | 1fl | Structure of Human Transthyretin Asp38Ala Mutant in Complex with Diflunisal | 6e78 | 50.01 |
| 34 | des | The orthorhombic crystal structure of transthyretin in complex with diethylstilbestrol | 1tt6 | 49.97 |
| 35 | agi | Crystal structure of transthyretin in complex with apigenin | 4wo0 | 49.93 |
| 36 | 6j3 | Crystal Structure of Human Transthyretin in Complex with Clonixin | 5l4i | 49.85 |
| 37 | lur | Crystal structure of human transthyretin in complex with lumiracoxib | 4ik6 | 49.61 |
| 38 | que | Crystal structure of Transthyretin-quercetin complex | 4wnj | 48.77 |
| 39 | imn | Crystal structure of human transthyretin in complex with indomethacin | 4ik7 | 48.54 |
| 40 | cjz | Human Transthyretin (TTR) complexed with 2-((3,5-dichloro-4-hydroxyphenyl)amino)benzoic acid | 3m1o | 48.43 |
| 41 | esz | Human transthyretin (TTR) complexed with 16-alpha-bromo-estradiol | 4pm1 | 48.42 |
| 42 | 18a | Kinetic stabilization of transthyretin through covalent modification of K15 by (E)-N-(4-(4-hydroxy-3,5-dimethylstyryl)phenyl)propionamide | 4hjt | 48.31 |
| 43 | g24 | V30M mutant human transthyretin (TTR) complexed with GC-24 (V30M:GC-24) | 3nex | 48.23 |
| 44 | a93 | Transthyretin in complex with a covalent small molecule kinetic stabilizer | 3hj0 | 48.22 |
| 45 | 9cr | TRANSTHYRETIN COMPLEX WITH RETINOIC ACID | 1tyr | 48.19 |
| 46 | agi | Crystal Structure of the Wild Type TTR Binding Apigenin (TTRwt:API) | 4der | 48.04 |
| 47 | b72 | V30M mutant human transthyretin (TTR) complexed with GC-1 (V30M:GC-1) | 3nes | 48.03 |
| 48 | 1w4 | Covalent modification of transthyretin K15 by yielding the fluorescent conjugate (E)-3-(dimethylamino)-5-(4-hydroxy-3,5-dimethylstyryl)benzamide | 4l1s | 47.8 |
| 49 | g24 | Wild type human transthyretin (TTR) complexed with GC-24 (TTRwt:GC-24) | 3neo | 47.74 |
| 50 | 6b5 | Crystal structure of human transthyretin in complex with luteolin-MeO at 1.35 A resolution | 5ihh | 47.56 |
| 51 | fq7 | Structure of human transthyretin complex with analgesic inhibitor | 6d0w | 46.87 |
| 52 | gbj | Crystal structure of human transthyretin complexed with glabridin | 4n86 | 46.64 |
| 53 | lu2 | Crystal structure of human transthyretin variant V30M in complex with luteolin | 4qya | 46.6 |
| 54 | 1fl | Structure of Human Transthyretin Val30Met Mutant in Complex with Diflunisal | 6e73 | 46.42 |
| 55 | flp | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH FLURBIPROFEN | 1dvt | 46.25 |
| 56 | gbj | Crystal structure of V30M mutant human transthyretin complexed with glabridin | 4n87 | 46.21 |
| 57 | lj5 | Human transthyretin (TTR) in complex with N-(3,5-Dibromo-4-hydroxyphenyl)benzamide | 3cn4 | 45.99 |
| 58 | pwh | Crystal structure of V30M mutant human transthyretin complexed with caffeic acid 1,1-dimethylallyl ester | 4pwh | 45.85 |
| 59 | kmp | Crystal Structure of the Wild Type TTR Binding Kaempferol (TTRwt:KAE) | 4det | 45.28 |
| 60 | fhi | Crystal structure of transthyretin in complex with iododiflunisal | 1y1d | 42.99 |
| 61 | lur | Crystal structure of wild-type human transthyretin in complex with lumiracoxib | 4iiz | 41.82 |
| 62 | 3ca | Human transthyretin (TTR) complexed with Diflunisal analogues- TTR.2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID | 2b77 | 41.11 |
| 63 | b72 | Wild type human transthyretin (TTR) complexed with GC-1 (TTRwt:GC-1) | 3nee | 40.94 |
| 64 | d75 | Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and their metabolites: daidzein-7-O- glucuronide | 5al8 | 40.52 |
| 65 | roa | Crystal structure of V30M mutant human transthyretin complexed with rosmarinic acid | 4pwi | 37.66 |
| 66 | imn | Crystal structure of wild-type human transthyretin in complex with indomethacin | 4iki | 33.35 |